← Evidence map

ArticleLeukemia2016

Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: the authors' reply.

T Bernal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2016
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 26754826